This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Oct;157(4):799-801.

doi: 10.1111/j.1365-2133.2007.08073.x. Epub 2007 Jul 16.

Bortezomib-associated cutaneous vasculitis

X Garcia-Navarro, L Puig, M T Fernández-Figueras, J Dalmau, E Roe, A Alomar

PMID: 17635511
DOI: 10.1111/j.1365-2133.2007.08073.x

Review

Bortezomib-associated cutaneous vasculitis

X Garcia-Navarro et al. Br J Dermatol. 2007 Oct.

. 2007 Oct;157(4):799-801.

doi: 10.1111/j.1365-2133.2007.08073.x. Epub 2007 Jul 16.

Authors

X Garcia-Navarro, L Puig, M T Fernández-Figueras, J Dalmau, E Roe, A Alomar

PMID: 17635511
DOI: 10.1111/j.1365-2133.2007.08073.x

No abstract available

PubMed Disclaimer

Similar articles

Images in clinical Medicine. Bortezomib-induced skin lesions.
Agterof MJ, Biesma DH. Agterof MJ, et al. N Engl J Med. 2005 Jun 16;352(24):2534. doi: 10.1056/NEJMicm041166. N Engl J Med. 2005. PMID: 15958809 No abstract available.
Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?
Gerecitano J, Goy A, Wright J, MacGregor-Cortelli B, Neylon E, Gonen M, Esseltine D, Boral A, Schenkein D, Busam K, Teruya-Feldstein J, Sachs D, O'Connor OA. Gerecitano J, et al. Br J Haematol. 2006 Aug;134(4):391-8. doi: 10.1111/j.1365-2141.2006.06201.x. Br J Haematol. 2006. PMID: 16882131 Clinical Trial.
Bortezomib-induced skin eruption.
Sanchez-Politta S, Favet L, Kerl K, Dietrich PY, Piguet V. Sanchez-Politta S, et al. Dermatology. 2008;216(2):156-8. doi: 10.1159/000111513. Epub 2008 Jan 23. Dermatology. 2008. PMID: 18216478
Sweet-like lesions induced by bortezomib: a review of the literature and a report of 2 cases.
Truchuelo M, Bagazgoitia L, Alcántara J, Velasco D, Carrillo R. Truchuelo M, et al. Actas Dermosifiliogr. 2012 Nov;103(9):829-31. doi: 10.1016/j.ad.2012.03.002. Epub 2012 May 30. Actas Dermosifiliogr. 2012. PMID: 22652505 Review. English, Spanish. No abstract available.
[Clinical development of a proteasome inhibitor, bortezomib, for the treatment of myeloma and lymphoma].
Tobinai K. Tobinai K. Rinsho Ketsueki. 2007 Jun;48(6):451-7. Rinsho Ketsueki. 2007. PMID: 17633092 Review. Japanese. No abstract available.

See all similar articles

Cited by

The future of proteasome inhibitors in relapsed/refractory multiple myeloma.
Orlowski RZ. Orlowski RZ. Oncology (Williston Park). 2011 Nov 15;25 Suppl 2(12 0 2):56-64. Oncology (Williston Park). 2011. PMID: 25188482 Free PMC article. Review.
Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two cases.
Gerber PA, Bölke E, Buhren BA, Bruch-Gerharz D, Fenk R, Reifenberger J, Budach W, Haas R, Homey B. Gerber PA, et al. Wien Klin Wochenschr. 2009;121(21-22):723-4. doi: 10.1007/s00508-009-1267-7. Wien Klin Wochenschr. 2009. PMID: 19998015 No abstract available.
Ixazomib-induced cutaneous necrotizing vasculitis.
Alloo A, Khosravi H, Granter SR, Jadeja SM, Richardson PG, Castillo JJ, LeBoeuf NR. Alloo A, et al. Support Care Cancer. 2018 Jul;26(7):2247-2250. doi: 10.1007/s00520-018-4052-1. Epub 2018 Feb 1. Support Care Cancer. 2018. PMID: 29392482
Bortezomib-Induced Superficial Vasculitis in a Kidney Transplant Recipient: A Rare Case.
Balwani M, Pasari A, Gurjar P, Sejpal K, Bawankule C, Tolani P, Dubey S, Kashiv P, Bhawane A, Malde S, Gupta S. Balwani M, et al. Cureus. 2024 Apr 22;16(4):e58743. doi: 10.7759/cureus.58743. eCollection 2024 Apr. Cureus. 2024. PMID: 38779283 Free PMC article.
Bortezomib-Induced Reticular Eruption in Patient with Multiple Myeloma.
Han J, Owji S, Agarwal A, Kamat S, Luu Y, Mubasher A, Niedt G, Ray C, Cho HJ, Gulati N, Lamb A. Han J, et al. Dermatopathology (Basel). 2023 Jul 21;10(3):226-230. doi: 10.3390/dermatopathology10030031. Dermatopathology (Basel). 2023. PMID: 37489455 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information